NEW YORK (NEXSTAR) – Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children as it moves closer to seeking approval for expanded ...

PHILADELPHIA -- Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking ...

(AP) — Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. NEW YORK — Pfizer has submitted research to ...

NEW YORK (WABC) -- The FDA is reviewing data on Pfizer's vaccine for children ages five to 11. One federal official told ABC News those shots could begin rolling out before Thanksgiving, a few weeks ...

(NewsNation Now) — Pfizer and partner BioNTech have asked U.S. health regulators to approve emergency use of their COVID-19 vaccine for children aged from 5 to 11, Pfizer confirmed Thursday. At this ...

WASHINGTON - The program to vaccinate children between 5 and 11 years old is expected to be at full strength next week, according to the White House. "Starting the week of November 8, the kids’ ...

COVID-19 vaccines for children between the ages of 5 and 11 could get the green light from the US Food and Drug Administration sometime this fall, Dr. Anthony Fauci said. "If you look at the studies ...

Pfizer and BioNTech said Monday that late-stage trials of its COVID-19 vaccine in children show that the shots were safe and effective in kids aged between 5 and 11. The results mark a key step in ...

Pfizer and BioNTech announced Tuesday that they had submitted data to the Food and Drug Administration in the hopes of having their COVID-19 vaccine approved for emergency use in kids aged 5 to 12. In ...